Sophiris Bio Inc. (SPHS) Stock Price & Overview

NASDAQ:SPHS

Current stock price

0.23
-0.35 (-60.3%)
At close:
0.2
-0.03 (-13.04%)
After Hours:

The current stock price of SPHS is 0.23 null. Today SPHS is down by -60.3%. In the past month the price decreased by -65.86%. In the past year, price decreased by -78.5%.

SPHS Key Statistics

52-Week Range0.23 - 1.17
Current SPHS stock price positioned within its 52-week range.
1-Month Range0.23 - 0.79
Current SPHS stock price positioned within its 1-month range.
Market Cap
8.177M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.33
Dividend Yield
N/A

SPHS Stock Performance

Today
-60.3%
1 Week
-67.04%
1 Month
-65.86%
3 Months
-37.07%
Longer-term
6 Months -69.33%
1 Year -78.50%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

SPHS Stock Chart

Sophiris Bio Inc. / SPHS Daily stock chart

SPHS Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to SPHS. When comparing the yearly performance of all stocks, SPHS is a bad performer in the overall market: 84.99% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
SPHS Full Technical Analysis Report

SPHS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SPHS. Both the profitability and financial health of SPHS have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SPHS Full Fundamental Analysis Report

SPHS Earnings

Next Earnings DateN/A
Last Earnings DateN/A
SPHS Earnings History

SPHS Forecast & Estimates


Analysts
Analysts100
Price TargetN/A
EPS Next Y34.62%
Revenue Next YearN/A
SPHS Forecast & Estimates

SPHS Financial Highlights

Over the last trailing twelve months SPHS reported a non-GAAP Earnings per Share(EPS) of -0.33000000000000007. The EPS increased by 31.25% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)37.00K
Industry RankSector Rank
PM (TTM) N/A
ROA 0.52%
ROE N/A
Debt/Equity -1.12
Chartmill High Growth Momentum
EPS Q2Q%36.36%
Sales Q2Q%N/A
EPS 1Y (TTM)31.25%
Revenue 1Y (TTM)N/A
SPHS financials

SPHS Ownership

Ownership
Inst Owners0%
Shares35.55M
Float32.33M
Ins Owners0.56%
Short Float %N/A
Short RatioN/A
SPHS Ownership

About SPHS

Company Profile

Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.

Company Info

Sophiris Bio Inc.

1258 PROSPECT STREET

LA JOLLA CA 92037

CEO: Randall E. Woods

Phone: 858-777-1760

Sophiris Bio Inc. / SPHS FAQ

What does SPHS do?

Sophiris Bio Inc. operates as a biopharmaceutical company. The Company is developing a treatment for benign prostatic hyperplasia (BPH or enlarged prostate). It has operations based in San Diego. Sophiris Bio Inc. is based in Canada.


Can you provide the latest stock price for Sophiris Bio Inc.?

The current stock price of SPHS is 0.23 null. The price decreased by -60.3% in the last trading session.


Does SPHS stock pay dividends?

SPHS does not pay a dividend.


What is the ChartMill rating of Sophiris Bio Inc. stock?

SPHS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the market capitalization of SPHS stock?

Sophiris Bio Inc. (SPHS) has a market capitalization of 8.18M null. This makes SPHS a Nano Cap stock.